1. Role of different GnRH agonist regimens in pituitary suppression and the outcome of controlled ovarian hyperstimulation
- Author
-
A. Falbo, Paolo Casadio, D. Spettoli, R. Arnone, Graciela Estela Cognigni, C. Tabarelli, R. Pecorari, W. Ciampaglia, F. Carbone, and Marco Filicori
- Subjects
Agonist ,endocrine system ,Pituitary gland ,medicine.medical_specialty ,medicine.drug_class ,media_common.quotation_subject ,medicine.medical_treatment ,Superovulation ,Gonadotropin-releasing hormone ,Controlled ovarian hyperstimulation ,Gonadotropin-Releasing Hormone ,Ovulation Induction ,Internal medicine ,medicine ,Humans ,Ovulation ,reproductive and urinary physiology ,media_common ,business.industry ,Rehabilitation ,Obstetrics and Gynecology ,medicine.anatomical_structure ,Endocrinology ,Reproductive Medicine ,Female ,Ovulation induction ,Gonadotropin ,business ,Gonadotropins ,hormones, hormone substitutes, and hormone antagonists ,Hormone - Abstract
Gonadotrophin-releasing hormone (GnRH) agonists have become irreplaceable addition to gonadotrophins in ovulation induction for assisted reproduction. Of the several schemes currently employed, long regimens appear to be maximally effective to optimize patient scheduling and to improve clinical results.
- Published
- 1996
- Full Text
- View/download PDF